Skip to main content
. 2019 Mar 19;14(4):567–575. doi: 10.2215/CJN.11010918

Table 3.

Proportion of patients with (Montreal Cognitive Assessment score <26) and without (Montreal Cognitive Assessment score ≥26) cognitive impairment active on the waitlist or transplanted, declared ineligible/removed from the list, inactive on the waitlist, and deferred for decision regarding listing or in evaluation after discussion in the selection committee at 1 month, 6 months, and 1 year after their initial evaluation

Time from First Evaluation Total Sample, n=349 Cognitive Impairment: MoCA<26, n=193 No Cognitive Impairment: MoCA≥26, n=156 P Value
Listed active or transplanted
 1 mo 20 (6) 3 (2) 17 (11) <0.001a
 6 mo 90 (26) 32 (17) 58 (37) <0.001a
 1 yr 109 (31) 45 (23) 64 (41) <0.001a
Ineligible/removed
 1 mo 61 (18) 48 (25) 13 (8) <0.001a
 6 mo 100 (29) 68 (35) 32 (21.2) 0.003b
 1 yr 137 (39) 88 (46) 49 (32) <0.01b
Listed inactive
 1 mo 2 (1) 0 2 (1) 0.38
 6 mo 15 (4) 7 (4) 8 (5) 0.67
 1 yr 19 (5) 9 (5) 10 (6) 0.63
Deferred or in evaluation
 1 mo 265 (76) 142 (74) 123 (79) 0.31
 6 mo 143 (41) 86 (45) 57 (37) 0.16
 1 yr 83 (24) 51 (26) 32 (21) 0.25

MoCA, Montreal Cognitive Assessment.

a

P<0.001.

b

P<0.01.